Publications by authors named "Alejandro Laso"

Claim this Profile
N
New bioisosteric sulphur-containing choline kinase inhibitors with a tracked mode of action.
Pilar M Luque-Navarro, M Paz Carrasco-Jiménez, Laura Goracci, Jose M Paredes, Laura Espinar-Barranco, Alejandro Laso

Eur J Med Chem· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Embedding Biomimetic Magnetic Nanoparticles Coupled with Peptide AS-48 into PLGA to Treat Intracellular Pathogens.
Salvatore Calogero Gaglio, Ylenia Jabalera, Manuel Montalbán-López, Ana Cristina Millán-Placer, Marina Lázaro-Callejón, Alejandro Laso

Pharmaceutics· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors.
Pilar María Luque-Navarro, Elena Mariotto, Marco Ballarotto, Gianluca Rubbini, Francisco José Aguilar-Troyano, Alejandro Laso

Pharmaceutics· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines.
Pablo García-Molina, Alberto Sola-Leyva, Pilar M Luque-Navarro, Alejandro Laso, Pablo Ríos-Marco

Pharmaceutics· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis